John Abele Insider Profile
4 Followers
John Abele, Director Emeritus at Boston Scientific, holds 17.41M shares in BETA Technologies, Inc. Class A (Ticker: BETA), holds 1.34M shares in Boston Scientific (Ticker: BSX).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+42.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Abele holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Abele
John Abele's Trading History
Boston Scientific
Aug 24, 2015
Director Emeritus
Informative Buy
3.35M
$70.81M
BETA Technologies, Inc. Class A
Apr 17, 2026
Director
Uninformative Buy
―
$268.34M
List of latest transactions for each holding click on a transaction to see John Abele's performance on stock
You May Also Like
John Abele insider profile FAQ
What is the percentage of profitable transactions made by John Abele?
The percentage of profitable transactions made by John Abele is 100%.
What is the average return per transaction made by John Abele?
The average return per transaction made by John Abele is 42.80%.
What stocks does John Abele hold?
John Abele holds: BSX, BETA stocks.
What was John Abele’s latest transaction?
John Abele latest transaction was an Uninformative Buy of ―.
What was John Abele's most profitable transaction?
John Abele’s most profitable transaction was an Informative Buy of BSX stock on August 24, 2015. The return on the trade was 49.00%.
What is John Abele's role in Boston Scientific?
John Abele's role in Boston Scientific is Director Emeritus.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.